NR 511 - WEEK 7 CLINICAL PRACTICE GUIDELINE PRESENTATION,(2020/21) DYSLIPIDEMIA - Already Graded A+ & Verified
NR 511 - WEEK 7 CLINICAL PRACTICE GUIDELINE PRESENTATION,(2020/21) DYSLIPIDEMIA - Already Graded A+ & Verified I am going to review the clinical practice guideline for the management of dyslipidemia and prevention of cardiovascular disease that was developed by the American Association of Clinical Endocrinologist and the American College of Endocrinology. Dyslipidemia is a broad term that refers to plasma that contains elevated levels of lipids. It is also considered to be the primary risk factor for the development of cardiovascular disease. This clinical practice guideline, or CPG, was developed to assist in screening, risk assessment and treatment of patients with dyslipidemia with the ultimate goal being to reduce the risk of cardiovascular disease and prevention of atherosclerosis.
Document information
- Uploaded on
- May 17, 2021
- Number of pages
- 4
- Written in
- 2020/2021
- Type
- Other
- Person
- Unknown